Literature DB >> 24078436

Familial isolated pituitary adenoma caused by a Aip gene mutation not described before in a family context.

J A García-Arnés, I González-Molero, J Oriola, N Mazuecos, R Luque, J Castaño, M A Arraez.   

Abstract

The cause of familial isolated pituitary adenomas (FIPA) remains unknown in a high percentage of cases, but the AIP gene plays an important role in the etiology. The aim of the study is to describe a family with FIPA syndrome and the results of genomic studies. A 16-year-old man had a giant prolactinoma resistant tomedical treatment with delayed growth and pubertal development. His mother had been previously diagnosed with a nonfunctioning pituitary macroadenoma. Transsphenoidal endoscopic resection was performed and a genetic study revealed a heterozygous mutation in exon 6: 974G>A (p.Arg325Gln). Because the AIP gene is a tumor suppressor gene, we searched for loss of heterozygosity within the AIP gene by amplifying exon 6 from tumor tissue of the patient. In the electropherogram, only the A allele was amplified (hemizygous state), indicating loss of the normal allele. We report a Spanish family with FIPA in whom a mutation in the AIP gene previously unreported in a familiar context was identified.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24078436     DOI: 10.1007/s12022-013-9268-5

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  18 in total

1.  Clinical characterization of familial isolated pituitary adenomas.

Authors:  A F Daly; M-L Jaffrain-Rea; A Ciccarelli; H Valdes-Socin; V Rohmer; G Tamburrano; C Borson-Chazot; B Estour; E Ciccarelli; T Brue; P Ferolla; P Emy; A Colao; E De Menis; P Lecomte; F Penfornis; B Delemer; J Bertherat; J L Wémeau; W De Herder; F Archambeaud; A Stevenaert; A Calender; A Murat; F Cavagnini; A Beckers
Journal:  J Clin Endocrinol Metab       Date:  2006-06-20       Impact factor: 5.958

2.  Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.

Authors:  Laure Cazabat; Jérôme Bouligand; Sylvie Salenave; Michèle Bernier; Stephan Gaillard; Fabrice Parker; Jacques Young; Anne Guiochon-Mantel; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2012-02-08       Impact factor: 5.958

3.  Higher prevalence of clinically relevant pituitary adenomas confirmed.

Authors:  Albert Beckers
Journal:  Clin Endocrinol (Oxf)       Date:  2009-10-15       Impact factor: 3.478

Review 4.  Familial pituitary tumor syndromes.

Authors:  Vladimir Vasilev; Adrian F Daly; Patrick Petrossians; Sabina Zacharieva; Albert Beckers
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

5.  Aggressive prolactinoma in a child related to germline mutation in the ARYL hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Luciana Ansaneli Naves; Marie-Lise Jaffrain-Rea; Sergio Alberto Cunha Vêncio; Clausmir Zaneti Jacomini; Luiz Augusto Casulari; Adrian F Daly; Albert Beckers
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-11

Review 6.  Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).

Authors:  Harvinder S Chahal; J Paul Chapple; Lawrence A Frohman; Ashley B Grossman; Márta Korbonits
Journal:  Trends Endocrinol Metab       Date:  2010-06-01       Impact factor: 12.015

7.  Familial pituitary adenomas - who should be tested for AIP mutations?

Authors:  Márta Korbonits; Helen Storr; Ajith V Kumar
Journal:  Clin Endocrinol (Oxf)       Date:  2012-09       Impact factor: 3.478

Review 8.  AIP and its interacting partners.

Authors:  Giampaolo Trivellin; Márta Korbonits
Journal:  J Endocrinol       Date:  2011-03-31       Impact factor: 4.286

9.  The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.

Authors:  Chrysanthia A Leontiou; Maria Gueorguiev; Jacqueline van der Spuy; Richard Quinton; Francesca Lolli; Sevda Hassan; Harvinder S Chahal; Susana C Igreja; Suzanne Jordan; Janice Rowe; Marie Stolbrink; Helen C Christian; Jessica Wray; David Bishop-Bailey; Dan M Berney; John A H Wass; Vera Popovic; Antônio Ribeiro-Oliveira; Monica R Gadelha; John P Monson; Scott A Akker; Julian R E Davis; Richard N Clayton; Katsuhiko Yoshimoto; Takeo Iwata; Akira Matsuno; Kuniki Eguchi; Mâdâlina Musat; Daniel Flanagan; Gordon Peters; Graeme B Bolger; J Paul Chapple; Lawrence A Frohman; Ashley B Grossman; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2008-04-01       Impact factor: 5.958

10.  Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.

Authors:  Susana Igreja; Harvinder S Chahal; Peter King; Graeme B Bolger; Umasuthan Srirangalingam; Leonardo Guasti; J Paul Chapple; Giampaolo Trivellin; Maria Gueorguiev; Katie Guegan; Karen Stals; Bernard Khoo; Ajith V Kumar; Sian Ellard; Ashley B Grossman; Márta Korbonits
Journal:  Hum Mutat       Date:  2010-08       Impact factor: 4.878

View more
  4 in total

1.  A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.

Authors:  Takeo Iwata; Shozo Yamada; Junko Ito; Naoko Inoshita; Noriko Mizusawa; Shinji Ono; Katsuhiko Yoshimoto
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 2.  Genetic mutations in sporadic pituitary adenomas--what to screen for?

Authors:  Anne-Lise Lecoq; Peter Kamenický; Anne Guiochon-Mantel; Philippe Chanson
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

3.  Germline mutations of aryl hydrocarbon receptor-interacting protein (AIP) gene and somatostatin receptor 1-5 and AIP immunostaining in patients with sporadic acromegaly with poor versus good response to somatostatin analogues.

Authors:  Hande Mefkure Ozkaya; Nil Comunoglu; Muge Sayitoglu; Fatma Ela Keskin; Sinem Firtina; Khusan Khodzhaev; Tugce Apaydin; Nurperi Gazioglu; Necmettin Tanriover; Buge Oz; Pinar Kadioglu
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

4.  Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations.

Authors:  Laura C Hernández-Ramírez; Federico Martucci; Rhodri M L Morgan; Giampaolo Trivellin; Daniel Tilley; Nancy Ramos-Guajardo; Donato Iacovazzo; Fulvio D'Acquisto; Chrisostomos Prodromou; Márta Korbonits
Journal:  J Clin Endocrinol Metab       Date:  2016-06-02       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.